Literature DB >> 15288006

Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity.

Yael Oppenheim1, Yoshiyuki Ban, Yaron Tomer.   

Abstract

Interferon (IFN) alpha treatment for various conditions has been associated with thyroid autoimmunity. The incidence of interferon induced thyroid autoimmunity has been reported to range from 2.5% to 42%, possibly depending upon dose and duration of medical therapy and patient characteristics. It is not known whether IFN-alpha initiates autoimmune thyroid disease (AITD) or simply exacerbates AITD in individuals with subclinical AITD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288006     DOI: 10.1016/j.autrev.2004.03.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

Review 1.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

2.  HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity.

Authors:  Nagako Akeno; Jason T Blackard; Yaron Tomer
Journal:  J Autoimmun       Date:  2008-09-16       Impact factor: 7.094

Review 3.  Hepatitis C and interferon induced thyroiditis.

Authors:  Yaron Tomer
Journal:  J Autoimmun       Date:  2010-05       Impact factor: 7.094

4.  De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case.

Authors:  Kazuki Takeishi; Ken Shirabe; Takeo Toshima; Toru Ikegami; Kazutoyo Morita; Takasuke Fukuhara; Takashi Motomura; Yohei Mano; Hideaki Uchiyama; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

Review 5.  Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.

Authors:  Bassem Refaat; Adel Galal El-Shemi; Ahmed Ashshi; Esam Azhar
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  TH17 deficiency in human disease.

Authors:  Douglas R McDonald
Journal:  J Allergy Clin Immunol       Date:  2012-05-01       Impact factor: 10.793

Review 7.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 8.  Interferon induced thyroiditis.

Authors:  Yaron Tomer; Francesca Menconi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

9.  Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.

Authors:  Alia Hasham; Weijia Zhang; Vaneet Lotay; Shannon Haggerty; Mihaela Stefan; Erlinda Concepcion; Douglas T Dieterich; Yaron Tomer
Journal:  J Autoimmun       Date:  2013-05-15       Impact factor: 7.094

10.  Amino acid sequence homologies between HCV polyprotein and thyroid antigens.

Authors:  A Martocchia; P Falaschi
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.